Spin-Off Surge: DePuy Synthes Sales Trigger

🚀 Battle Card: DePuy Synthes (Johnson & Johnson Orthopaedics)

• Namal Nawana, Worldwide President · 🔗 [LinkedIn](https://www.linkedin.com/company/johnson-&-johnson/)

• This DePuy Synthes sales trigger creates the largest standalone orthopaedics-focused company, demanding focused separation and value-creation partnerships. → Source

• Complex spin-off execution across global operations

• Maintaining top-line growth & margin improvement post-separation

• Primary: M&A integration & change-management services → minimize disruption and accelerate spin-off timelines

• Expansion: Supply chain & ERP optimization → drive margin improvement and operational agility (Leverage the DePuy Synthes sales trigger to position these solutions as mission-critical.)

• HQ: New Brunswick, NJ

• Employees: ≈ 20,000

• Rev: ≈ $9.2 B (FY2024)

• Website: [jnj.com](https://www.jnj.com/)

🤼 Competitive Intel

• Deloitte — M&A advisory & integration
• Unique edge: Comprehensive carve-out playbook for Fortune 100 separations
• Evaluated by Finance & Corporate Dev for transaction risk mitigation

• PwC — Transaction tax & structuring
• Unique edge: Global tax optimization on spin-off structures
• Evaluated by CFO for post-separation balance sheet impact

• KPMG — Carve-out & separation planning
• Unique edge: End-to-end separation blueprint and governance
• Evaluated by HR & Operations for employee transition frameworks

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑<your company>❑
OFFER_BRIEF   = ❑M&A integration & change-management services❑
PROOF_METRIC  = ❑30% reduction in downtime❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑punchy❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Namal
COMPANY     = DePuy Synthes (Johnson & Johnson Orthopaedics)
DEPT        = Finance
SIZE        = 100
BOTTLENECK  = Complex spin-off execution
EVENT       = Intent to separate its Orthopaedics business
DETAIL      = Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
PAIN        = Maintaining top-line growth & margin improvement post-separation
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20251014819650&div=41152219
SIM_CO      = Stryker
WIN_METRIC  = 25% faster separation timeline
NEXT_SIZE   = 500
EMP_EST     = ≈ 20,000
REV_EST     = ≈ $9.2B

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: 100-person Finance

Namal—noticed your Finance team is ≈ 100.

That’s when Complex spin-off execution slows growth.

We helped Stryker fix this with M&A integration & change-management services.

Result: 25% faster separation timeline.  
Quick call?

PS—next bottleneck hits ≈ 500.

DM ≤45 words, TONE:
Saw your post about Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business — Maintaining top-line growth & margin improvement post-separation.  
M&A integration & change-management services. 30% reduction in downtime.  
Quick chat?